This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Fondazione Istituto Italiano Di Tecnologia, Università Degli Studi Di Roma "La Sapienza". Active years: 2021.
Company Filing History:
1 out of 147 
1 out of 63 
Years Active: 2021
Title: The Innovative Contributions of Isabella Screpanti
Introduction
Isabella Screpanti is a notable inventor based in Rome, Italy. She has made significant strides in the field of medical research, particularly in the treatment of T-cell acute lymphoblastic leukemia. Her work has the potential to impact the lives of many patients suffering from this aggressive form of cancer.
Latest Patents
Isabella holds a patent for "Notch inhibitors for use in the treatment of T-cell acute lymphoblastic leukemia." This patent describes compounds of formula (I) that exhibit anti-tumor activity, specifically targeting T-cell acute lymphoblastic leukemia (T-ALL). This innovative approach could lead to more effective treatments for patients battling this disease.
Career Highlights
Throughout her career, Isabella has been associated with prestigious institutions such as Università Degli Studi Di Roma "La Sapienza" and Fondazione Istituto Italiano Di Tecnologia. Her work in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Isabella has worked alongside talented individuals such as Deborah Quaglio and Rocco Palermo. These collaborations have enriched her research and expanded the scope of her innovative projects.
Conclusion
Isabella Screpanti's contributions to the field of medical research, particularly in the treatment of T-cell acute lymphoblastic leukemia, highlight her role as a pioneering inventor. Her patent and collaborations reflect her commitment to advancing healthcare solutions.